Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,404 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A wave of brokerage consolidation is reshaping the 2026 housing market. Industry leaders insist consolidation isn’t c...
JPMorgan's JEPI ETF offers a compelling income stream through covered calls on a diversified 110-name portfolio. This...
A 60-year-old who converted $400,000 to a Roth IRA in 2025 plans a $50,000 withdrawal in 2026, only to confront two s...
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
SOXX and SMH track similar themes but differ in holdings breadth and index rules, fueling a clear performance split i...
Micron is set to report earnings in June, and investors are laser-focused on a single number that could redefine MU’s...
SpaceX just shook the investor world again with a massive bond offering. This article breaks down what spacex's fundr...
Keel Infrastructure surged as it secured a large convertible financing to fuel AI data centers. This article breaks d...
As volatility stays elevated, a hedge against rising option premiums is gaining attention. The 8%-yield S&P 500 Premi...
A once factory-floor worker turned wealth-builder remains active in finance at age 62, choosing public transit and on...
Ciena’s shares jumped sharply in the first half of 2026. This article dives into the AI-driven demand for optical net...